PubRank

S Kesten

Author PubWeight™ 79.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 2003 4.53
2 Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002 3.66
3 Regular vs as-needed inhaled salbutamol in asthma control. Lancet 1994 3.59
4 Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008 3.13
5 Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994 2.15
6 Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J 2007 2.03
7 Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J 2010 2.01
8 Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001 1.69
9 Physiologic and nonphysiologic determinants of aerobic fitness in mild to moderate asthma. Am Rev Respir Dis 1992 1.66
10 Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J 2009 1.52
11 Bronchiolitis obliterans after lung transplantation: a review. Chest 1998 1.45
12 Adverse effects of inhaled corticosteroids. Am J Med 1995 1.39
13 Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000 1.20
14 Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis 2009 1.19
15 Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. Pulm Pharmacol Ther 2005 1.19
16 One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther 2004 1.17
17 Tolerance to bronchodilating effects of salmeterol in COPD. Respir Med 2003 1.15
18 The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant 1997 1.14
19 Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995 1.13
20 Comparison of hallway and treadmill six-minute walk tests. Am J Respir Crit Care Med 1999 1.11
21 Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler. Respir Med 1993 1.10
22 Extrathoracic angiomyolipomas in lymphangioleiomyomatosis. Eur Respir J 1996 1.08
23 Aspergillus infection in single and double lung transplant recipients. Transplantation 1996 1.06
24 COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Respir Med 2010 1.05
25 Factors associated with emergency department dependence of patients with asthma. Chest 1997 1.04
26 Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation 1997 1.04
27 Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity. J Aerosol Med 2001 1.03
28 Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med 2007 1.01
29 Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir Med 2013 0.96
30 Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J 2009 0.94
31 Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction. Respir Med 2003 0.93
32 Variability in performance of timed walk tests in pulmonary rehabilitation programs. Chest 2000 0.93
33 Pleural complications in lung transplant recipients. J Thorac Cardiovasc Surg 1995 0.90
34 Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms. Chest 1996 0.88
35 Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection. Am J Respir Crit Care Med 1998 0.88
36 Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients. Chest 1996 0.88
37 Causes of death in lung transplant recipients. J Heart Lung Transplant 1995 0.87
38 The placebo effect in asthma drug therapy trials: a meta-analysis. J Asthma 2000 0.87
39 Return to work after lung transplantation. J Heart Lung Transplant 1998 0.86
40 Hepatitis C virus infection and lung transplantation: a survey of practices. J Heart Lung Transplant 1999 0.86
41 Quality of life in female lung transplant candidates and recipients. Chest 1997 0.85
42 Assessment of an ambulatory care asthma program. J Asthma 1994 0.85
43 Status of lung transplant recipients surviving beyond five years. J Heart Lung Transplant 1997 0.84
44 Miliary pulmonary cryptococcosis in a patient with the acquired immunodeficiency syndrome. Thorax 1993 0.83
45 Effect of tiotropium bromide on the cardiovascular response to exercise in COPD. Respir Med 2007 0.82
46 Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 2006 0.82
47 Severe pulmonary hypertension associated with COPD. Ann Transplant 2000 0.82
48 Asthma and allergy avoidance knowledge and behavior in postpartum women. Ann Allergy Asthma Immunol 1997 0.81
49 Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 1996 0.81
50 Prehospitalization inhaled corticosteroid use in patients with COPD or asthma. Chest 1997 0.81
51 Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest 1993 0.81
52 Analysis of the T cell receptor Vgamma region gene repertoire in bronchoalveolar lavage (BAL) and peripheral blood of atopic asthmatics and healthy subjects. Clin Exp Immunol 1996 0.80
53 Effects of high-dose inhaled fluticasone propionate via spacer on cell-mediated immunity in healthy volunteers. Chest 2000 0.80
54 The acute effects of nasal positive pressure ventilation in patients with advanced cystic fibrosis. Chest 1998 0.80
55 Lung volume reduction surgery: an analysis of hospital costs. Chest 1998 0.80
56 A retrospective comparative study of in-hospital management of acute severe asthma: 1984 vs 1989. Chest 1993 0.79
57 Bronchial hyperreactivity after lung transplantation predicts early bronchiolitis obliterans. Am J Respir Crit Care Med 1999 0.78
58 Canada's First National Conference on Asthma and Education. Consideration of public programs and techniques for public/community health education. Chest 1994 0.78
59 Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin. Chest 1998 0.78
60 Skeletal muscle dysfunction in lung transplantation. J Heart Lung Transplant 2000 0.77
61 A 3-month evaluation of the efficacy of nedocromil sodium in asthma: a randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group. J Allergy Clin Immunol 1990 0.77
62 Acute lung injury in lung allografts. J Heart Lung Transplant 1995 0.77
63 Diaphragmatic paralysis: a complication of lung transplantation. Ann Thorac Surg 1996 0.77
64 Comorbidities in end-stage lung disease. J Heart Lung Transplant 1999 0.76
65 Gas trapping as a predictor of positive methacholine challenge in patients with normal spirometry results. Chest 1995 0.75
66 Is survival that important? J Heart Lung Transplant 1998 0.75
67 Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens. Transplant Proc 1993 0.75
68 Previous intrapleural procedures do not adversely affect lung transplantation. J Heart Lung Transplant 1996 0.75
69 Infections in lung transplant recipients. Clin Chest Med 1997 0.75
70 Bronchodilator responsiveness in patients with COPD (data from the UPLIFT trial). Rev Port Pneumol 2015 0.75
71 Bronchodilator response at low lung volumes predicts bronchiolitis obliterans in lung transplant recipients. Chest 1996 0.75
72 Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Rev Port Pneumol 2015 0.75
73 Asthma education. A time for reappraisal. Chest 1995 0.75
74 Cavitary aspergillosis as a complication of AIDS. Can Assoc Radiol J 1993 0.75
75 Mass media and transplantation. J Heart Lung Transplant 1998 0.75
76 Multi-organ donor transmission of hepatitis C virus to five solid organ transplant recipients and lack of transmission to corneal transplant recipients. Clin Diagn Virol 1995 0.75